APA (7th ed.) Citation

JB, A., S, S., M, L., N, K., F, S., PS, S., . . . M, M. (2021). The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies. Multiple sclerosis and related disorders, 53, 103012. https://doi.org/10.1016/j.msard.2021.103012

Chicago Style (17th ed.) Citation

JB, Andersen, et al. "The Effectiveness of Natalizumab Vs Fingolimod-A Comparison of International Registry Studies." Multiple Sclerosis and Related Disorders 53 (2021): 103012. https://doi.org/10.1016/j.msard.2021.103012.

MLA (9th ed.) Citation

JB, Andersen, et al. "The Effectiveness of Natalizumab Vs Fingolimod-A Comparison of International Registry Studies." Multiple Sclerosis and Related Disorders, vol. 53, 2021, p. 103012, https://doi.org/10.1016/j.msard.2021.103012.